Patent · US Active

Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof

US8071717B2 · kind B2 · utility

0Cited by

6References

2Claims

0Family size

Assignee

LUDWIG INSTITUTE FOR CANCER RESEARCH LTD · GB

Inventors

Dirk Jager · New York, US
Elisabeth Stockert · New York, US
Matthew Scanlan · Princeton Junction, US
Alexander Knuth · Frankfurt am Main, DE
Lloyd J. Old · New York, US
Ali Gure · New York, US
Yao-Tseng Chen · New York, US
Elke Jager · Frankfurt am Main, DE

Key dates

Filing date	Oct 27, 2009
Grant date	Dec 6, 2011
Priority date	—
Expiry date	Jan 19, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention relates to newly identified cancer associated antigens. It has been discovered that each of these molecules provokes antibodies when expressed by a subject. The ramifications of this observation are also a part of this invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.